JPRN-UMIN000014609
Suspended
未知
The head-to-head comparison between escitalopram and mirtazapine for anxiety and agitation on the patients with depression, especially for the efficacy and safety. - The head-to-head comparison between escitalopram and mirtazapine on the patients with depression.
europsychiatry dept., Osaka Medical College0 sites80 target enrollmentJuly 23, 2014
Conditionsdepression
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- depression
- Sponsor
- europsychiatry dept., Osaka Medical College
- Enrollment
- 80
- Status
- Suspended
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •The patients who does not have the insight
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 3
Treatment of depressive symptoms in patients with heart failureDepression.Major depressive disorder, single episode, mildF32.0IRCT20190525043700N5Babol University of Medical Sciences80
Completed
Phase 2
Evaluation of the effect of Escitalopram versus placebo trial on changing the neuroticismeuroticism or neuroticism.Post-traumatic stress disorder, acuteF43.11IRCT20211208053331N1Ahvaz University of Medical Sciences172
Completed
Not Applicable
Comparative Effect of Citalopram and Escitalopram in the Patients with SchizophreniaIRCT20190525043700N1Babol University of Medical Sciences60
Completed
Not Applicable
Efficacy and tolerability of escitalopram versus paroxetine-CR in Japanese patients with major depressive disorder: a randomized, masked-rater trialmajor depressive disorderJPRN-UMIN000011191Department of Psychiatry, Fujita Health University School of Medicine200
Recruiting
Phase 2
Efficacy of Escitalopram, Venlafaxine and Buspirone in Irritable Bowel SyndromeIrritable bowel syndrome.Irritable bowel syndromeIRCT20150630022991N10Babol University of Medical Sciences90